← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Biotime, Inc.
Alameda, CA
$3,939,561
Total funding
7
Grants
Funding over time
peak $847.9K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,939,561 · 7
By mechanism
R44$2,230,814 · 1
R43$1,123,334 · 4
R41$299,990 · 1
N43$285,423 · 1
Investigators at Biotime, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Retinal tissue derived from human pluripotent stem cells for vision restoration$816,848
R44 · FY2017 · EY
Retinal tissue derived from human pluripotent stem cells for vision restoration$743,345
R44 · FY2018 · EY
Retinal tissue derived from human pluripotent stem cells for vision restoration$670,621
R44 · FY2019 · EY
Biodegradable, hyaluronic acid-based microcarriers for mesenchymal stem cell prop$335,900
R43 · FY2011 · GM
Rapid Multiplexed Nanoprobe Assays for Pluripotent Stem Cell Differentiation$292,261
R43 · FY2013 · GM
HIGH CONTENT SCREENING OF 3D CULTURED CANCER CELLS$285,423
N43 · FY2013 · CA
Reagents for Targeted Ablation of Residual Contaminating Pluripotent Stem Cells$270,262
R43 · FY2013 · GM
Cell Targeting Peptides for Isolating Patient Specific Stem Cells$224,911
R43 · FY2014 · GM
Resuscitating Blood-Substituted Hypothermic Dogs$149,996
R41 · FY2005 · HL
Resuscitating Blood-Substituted Hypothermic Dogs$149,994
R41 · FY2004 · HL